I do agree that this bodes well for continuing evolution of the way the medical world views the potential for cannabinoids . It’s nice, but it’s not a huge driver for GW Pharma.” The Epidiolex results show further progress in the medical and evidence-based use of cannabinoids , said Aras Azadian, CEO of … Read More
The post Why GW Pharma’s Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics appeared first on Dagga Magazine.